Aerosolized vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection in cystic fibrosis

Pediatr Pulmonol. 1998 Oct;26(4):287-9. doi: 10.1002/(sici)1099-0496(199810)26:4<287::aid-ppul9>3.0.co;2-#.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Inhalation
  • Aerosols
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Cystic Fibrosis / complications*
  • Humans
  • Lung Diseases / drug therapy*
  • Lung Diseases / microbiology
  • Male
  • Methicillin Resistance*
  • Staphylococcal Infections / drug therapy*
  • Staphylococcus aureus / drug effects
  • Vancomycin / administration & dosage*
  • Vancomycin / therapeutic use

Substances

  • Aerosols
  • Anti-Bacterial Agents
  • Vancomycin